Research Article

The prevalence and risk factors of chronic kidney disease among type 2 diabetes mellitus follow-up patients at Debre Berhan Referral Hospital, Central Ethiopia

Getaneh Baye Mulu, Worku Misganew Kebede, Fetene Nigussie Tarekegn, Abayneh Shewangzaw Engida, Migbaru Endawoke Tiruye, Mulat Mossie Menalu, Yalew Mossie, Wubshet Teshome and Bantalem Tilaye Atinafu*

Published: 20 February, 2023 | Volume 7 - Issue 1 | Pages: 025-031

Background: Chronic kidney disease is a progressive loss in renal function that is more accepted as global public health importance and its magnitude is overgrowing in the least developed countries like Ethiopia. No data was found in Debre Birhan Central Ethiopia on the magnitude of chronic kidney disease among type 2 diabetes patients. 
Methods: Institution-based cross-sectional study was conducted among 327 at Debre Berhan Referral Hospital from March to June 2019 in Adult (≥ 18 years) type 2 diabetes follow-up patients who volunteered to give informed written consent were included in the study. Systematic random sampling was used. Data were collected by interviews using structured and pre-tested questionnaires. Descriptive statistics of the continuous and categorical variables were done. The bi-variable and multivariable logistic regression was done to show the net effect of explanatory variables on chronic renal disease. 
Results: A total of 327 study participants were involved in the final analysis. The Prevalence of CKD among type 2 diabetic patients was 15.9%. A significant association was found with age > 60 years [AOR 3.5 (95% CI 1.8-6.8)], alcoholic patients [AOR 2.4 (95% CI 1.2-5.1)], glycated hemoglobin levels above 7% [AOR 2.5 (95 CI 1.5-4.1)], higher level of LDL greater than 100 g/dl [AOR 2.7 (95% CI 1.9-4)] and lower level of HDL [AOR 2.9 (95% CI 1.4-6)].
Conclusion: The magnitude of chronic kidney disease among type 2 diabetic follow-up patients was 15.9%. Estimated GFR should be determined for diabetic patients at regular intervals of time for earlier diagnosis of chronic kidney disease.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001104 Cite this Article Read Full Article PDF


Chronic kidney disease; Magnitude; Risk factors; Debre Berhan


  1. Bahrey D, Gebremedhn G, Mariye T, Girmay A, Aberhe W, Hika A, Teklay G, Tasew H, Zeru T, Gerensea H, Demoz GT. Prevalence and associated factors of chronic kidney disease among adult hypertensive patients in Tigray teaching hospitals: a cross-sectional study. BMC Res Notes. 2019 Sep 9;12(1):562. doi: 10.1186/s13104-019-4610-8. PMID: 31500655; PMCID: PMC6734391.
  2. Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A, Pepió JM, Roura P, Benito B, Franch-Nadal J, Saez M. Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol. 2012 Aug 20;13:87. doi: 10.1186/1471-2369-13-87. PMID: 22905926; PMCID: PMC3537582.
  3. Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, Abebe M. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018 Nov;28(6):691-700. doi: 10.4314/ejhs.v28i6.3. PMID: 30607085; PMCID: PMC6308752.
  4. De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Pontremoli R; and the AMD-Annals Study Group. Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative. Medicine (Baltimore). 2016 Jul;95(27):e4007. doi: 10.1097/MD.0000000000004007. Erratum in: Medicine (Baltimore). 2016 Dec 09;95(49):e5660. PMID: 27399078; PMCID: PMC5058807.
  5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. PMID: 12485966.
  6. Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A, Coresh J. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013; 3(1):5-14.
  7. African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. Lancet. 2021 May 22;397(10288):1885-1894. doi: 10.1016/S0140-6736(21)00441-4. Erratum in: Lancet. 2021 Jun 26;397(10293):2466. PMID: 34022988; PMCID: PMC8137309.
  8. Habtewold TD, Tsega WD, Wale BY. Diabetes Mellitus in Outpatients in Debre Berhan Referral Hospital, Ethiopia. J Diabetes Res. 2016;2016:3571368. doi: 10.1155/2016/3571368. Epub 2016 Jan 6. PMID: 26881245; PMCID: PMC4736777.
  9. Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, Ongaiyooth L, Vanavanan S, Sirivongs D, Thirakhupt P, Mittal B, Singh AK; Thai-SEEK Group. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010 May;25(5):1567-75. doi: 10.1093/ndt/gfp669. Epub 2009 Dec 27. PMID: 20037182.
  10. Kumela Goro K, Desalegn Wolide A, Kerga Dibaba F, Gashe Fufa F, Wakjira Garedow A, Edilu Tufa B, Mulisa Bobasa E. Patient Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease among Diabetes Mellitus and Hypertensive Patients at Jimma University Medical Center, Ethiopia. Biomed Res Int. 2019 May 12;2019:2383508. doi: 10.1155/2019/2383508. PMID: 31214611; PMCID: PMC6535886.
  11. Kuo IC, Lin HY, Niu SW, Hwang DY, Lee JJ, Tsai JC, Hung CC, Hwang SJ, Chen HC. Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease. Sci Rep. 2016 Jan 28;6:20028. doi: 10.1038/srep20028. PMID: 26818011; PMCID: PMC4730215.
  12. Lebov JF, Valladares E, Peña R, Peña EM, Sanoff SL, Cisneros EC, Colindres RE, Morgan DR, Hogan SL. A population-based study of prevalence and risk factors of chronic kidney disease in León, Nicaragua. Can J Kidney Health Dis. 2015 Feb 24;2:6. doi: 10.1186/s40697-015-0041-1. PMID: 25926994; PMCID: PMC4414463.
  13. Ohta M, Babazono T, Uchigata Y, Iwamoto Y. Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes. Diabet Med. 2010 Sep;27(9):1017-23. doi: 10.1111/j.1464-5491.2010.03049.x. PMID: 20722675.
  14. Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010;30(1):78-86. doi: 10.3265/Nefrologia.pre2009.Dic.5732. Epub 2009 Dec 14. PMID: 20038967.
  15. Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR; CDC CKD Surveillance Team. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010 Apr;5(4):673-82. doi: 10.2215/CJN.07891109. Epub 2010 Mar 25. PMID: 20338960; PMCID: PMC2849697.
  16. Roderick P, Roth M, Mindell J. Prevalence of chronic kidney disease in England: findings from the 2009 health survey for England. J Epidemiol Community Health. 2011; 65(Suppl 2): A12-A12.
  17. Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X, Barrot-De la Puente J, Coll-de Tuero G; RedGDPS Study Group. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol. 2013 Feb 22;14:46. doi: 10.1186/1471-2369-14-46. PMID: 23433046; PMCID: PMC3598539.
  18. Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J. 2011 Sep;162(3):548-54. doi: 10.1016/j.ahj.2011.06.006. Epub 2011 Aug 9. PMID: 21884875.
  19. van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Gussekloo J, Dekker FW, Groeneveld Y. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract. 2010 Dec;60(581):884-90. doi: 10.3399/bjgp10X544041. PMID: 21144198; PMCID: PMC2991741.
  20. Yacoub R, Habib H, Lahdo A, Al Ali R, Varjabedian L, Atalla G, Kassis Akl N, Aldakheel S, Alahdab S, Albitar S. Association between smoking and chronic kidney disease: a case control study. BMC Public Health. 2010 Nov 25;10:731. doi: 10.1186/1471-2458-10-731. PMID: 21108832; PMCID: PMC3004836.
  21. Yang L, Chu TK, Lian J, Lo CW, Lau PK, Nan H, Liang J. Risk factors of chronic kidney diseases in Chinese adults with type 2 diabetes. Sci Rep. 2018 Oct 2;8(1):14686. doi: 10.1038/s41598-018-32983-1. PMID: 30279452; PMCID: PMC6168551.


Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?